This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allscripts Healthcare Solutions Inc (MDRX)

NASDAQ: Technology

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 1.38B 1.37B 1.45B 1.44B
Cost of Sales 688.91M 691.04M 725.19M 683.46M
Gross Operating Profit 688.97M 682.02M 721.13M 760.62M
Selling, General, and Administrative Expenses 358.68M 419.60M 384.37M 387.57M
Research & Development 192.82M 199.75M 162.16M 104.11M
Operating Income before D & A (EBITDA) 137.47M 62.67M 174.61M 268.94M
Depreciation & Amortization 174.26M 178.81M 150.23M 132.40M
Interest Income 0.00 0.00 0.00 1.69M
Other Income - Net 368.00K 7.31M -14.54M 0.00
Special Income / Charges -2.39M -11.45M -11.10M 0.00
Total Income Before Interest Expenses (EBIT) -38.82M -120.29M -1.27M 138.23M
Interest Expense 29.30M 28.05M 16.19M 20.75M
Pre-Tax Income -68.12M -148.35M -17.46M 117.48M
Income Taxes -1.66M -44.32M -16.31M 43.87M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -66.45M -104.03M -1.15M 73.61M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -66.45M -104.03M -1.15M 73.61M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -66.45M -104.03M -1.15M 73.61M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-64.06M -92.57M 9.95M 73.61M
Preferred Dividends
Net Income Available To Common -66.45M -104.03M -1.15M 73.61M
Basic EPS from Continuing Ops. -0.37 -0.59 -0.01 0.39
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.37 -0.59 -0.01 0.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.37 -0.59 -0.01 0.39
Basic Normalized Net Income/Share -0.36 -0.52 0.06 0.39
EPS fr Continuing Ops. -0.37 -0.59 -0.01 0.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.37 -0.59 -0.01 0.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.37 -0.59 -0.01 0.39
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.36 -0.52 0.06 0.39
Dividends Paid per Share 0.00 0.00 0.00 0.00
MDRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

MDRX Allscripts Healthcare Solutions Inc

Chart of MDRX

Analysts Ratings for MDRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 9 9
Moderate Buy 1 1 1 1
Hold 12 13 12 13
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MDRX ANALYST REPORT

MDRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs